Hepatobiliary, Pancreas, Adrenal, Melanoma, and GIST
Author:
Wassef Heidi,Ho Linh T.
Publisher
Springer New York
Reference30 articles.
1. Anderson CD, Rice MH, Pinson CW, et al. Fluorodeoxyglucose PET imaging in the evaluation of gallbladder carcinoma and cholangiocarcinoma. J Gastrointest Surg. 2004;8(1):90–7.
2. Assie G, Antoni G, Tissier F, et al. Prognostic parameters of metastatic adrenocortical carcinoma. J Clin Endocrinol Metab. 2007;92(1):148–54.
3. Bertz-Lepel J, Rahm J, Pink D, et al. Influence of PET/CT on therapeutic management after resection of high-risk or very high-risk GIST. J. Clin Oncol 2011;29(suppl; abstr e20516).
4. Blake MA, Slattery JM, Kaira MK. Adrenal lesions: characterization with fused PET/CT image in patients with proved or suspected malignancy—initial experience. Radiology. 2006;238:970–7.
5. Chin BB, Wahl RL. 18F-Fluoro-2-deoxyglucose positron emission tomography in the evaluation of gastrointestinal malignancies. Gut. 2003;52 Suppl 4:iv23–9.